| Dr Shannon Ann Hunter, LPCS, LCDC | |
|
6628 Shadyview Dr, Antioch, TN 37013-5655 | |
| (409) 927-0944 | |
| Not Available |
| Full Name | Dr Shannon Ann Hunter |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 6628 Shadyview Dr, Antioch, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275637613 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 18861 (Texas) | Secondary |
| 101YP2500X | Counselor - Professional | 18861 (Texas) | Primary |
| Entity Name | Brightside Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801355482 PECOS PAC ID: 6608262464 Enrollment ID: O20230403000549 |
News Archive
New research from BYU published in PLOS Medicine found that providing medical patients with social support leads to an increased chance of survival and elongation of life.
The H1N1 flu epidemic has lessons to offer health care providers. The limited amount of vaccine available initially left pregnant women, small children with medical conditions, and other high-risk populations waiting in long lines. The problems encountered in reaching certain segments of the population apply to the provision of dental care as well as other disciplines.
Among nonsmokers who had diabetes, those who took the diabetes drug metformin had a decrease in lung cancer risk, according to a study in Cancer Prevention Research, a journal of the American Association for Cancer Research, by Lori Sakoda, PhD, MPH, research scientist at the Kaiser Permanente Division of Research in Oakland, California.
Avila Therapeutics™, Inc., a biotechnology company developing targeted covalent drugs, announced today that it has initiated a phase 1 clinical trial to assess the safety, tolerability and pharmacokinetic profile of AVL-292, a novel, orally available, covalent drug that targets Bruton's tyrosine kinase (Btk). AVL-292 is the first product candidate to enter clinical evaluation from Avila's proprietary covalent drug platform, Avilomics™.
Hopefully, summer won't end the way it began. Memorial Day celebrations helped set off a wave of coronavirus infections across much of the South and West. Gatherings around the Fourth of July seemed to keep those hot spots aflame.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shannon Ann Hunter, LPCS, LCDC 6628 Shadyview Dr, Antioch, TN 37013-5655 Ph: (409) 927-0944 | Dr Shannon Ann Hunter, LPCS, LCDC 6628 Shadyview Dr, Antioch, TN 37013-5655 Ph: (409) 927-0944 |
News Archive
New research from BYU published in PLOS Medicine found that providing medical patients with social support leads to an increased chance of survival and elongation of life.
The H1N1 flu epidemic has lessons to offer health care providers. The limited amount of vaccine available initially left pregnant women, small children with medical conditions, and other high-risk populations waiting in long lines. The problems encountered in reaching certain segments of the population apply to the provision of dental care as well as other disciplines.
Among nonsmokers who had diabetes, those who took the diabetes drug metformin had a decrease in lung cancer risk, according to a study in Cancer Prevention Research, a journal of the American Association for Cancer Research, by Lori Sakoda, PhD, MPH, research scientist at the Kaiser Permanente Division of Research in Oakland, California.
Avila Therapeutics™, Inc., a biotechnology company developing targeted covalent drugs, announced today that it has initiated a phase 1 clinical trial to assess the safety, tolerability and pharmacokinetic profile of AVL-292, a novel, orally available, covalent drug that targets Bruton's tyrosine kinase (Btk). AVL-292 is the first product candidate to enter clinical evaluation from Avila's proprietary covalent drug platform, Avilomics™.
Hopefully, summer won't end the way it began. Memorial Day celebrations helped set off a wave of coronavirus infections across much of the South and West. Gatherings around the Fourth of July seemed to keep those hot spots aflame.
› Verified 3 days ago
Chelsea Bates, Counselor Medicare: Not Enrolled in Medicare Practice Location: 5050 Blue Hole Rd, Antioch, TN 37013 Phone: 615-988-0353 | |
Kurrissa K Johnson, LCMHCA Counselor Medicare: Not Enrolled in Medicare Practice Location: 4001 Cane Ridge Pkwy, Antioch, TN 37013 Phone: 615-525-8746 | |
Ms. Christal Pennic, LPC MHSP Counselor Medicare: Not Enrolled in Medicare Practice Location: 639 Bradburn Village Cir, Antioch, TN 37013 Phone: 615-533-3548 | |
Loretta Powell, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3621 Longhaven Xing, Antioch, TN 37013 Phone: 615-593-0124 Fax: 615-280-6524 | |
Toy Lisa Mitchell, PH.D Counselor Medicare: Not Enrolled in Medicare Practice Location: 4804 Trappers Rdg, Antioch, TN 37013 Phone: 502-821-9732 | |
Kianah Vanlier, Counselor Medicare: Not Enrolled in Medicare Practice Location: 704 Reeves Rd, Antioch, TN 37013 Phone: 615-600-8036 |